Callan Family Office LLC Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Callan Family Office LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 14,451 shares of the medical equipment provider’s stock, valued at approximately $7,543,000.

Several other hedge funds have also recently bought and sold shares of ISRG. Howard Capital Management Group LLC boosted its stake in shares of Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after buying an additional 92 shares during the period. Avidian Wealth Enterprises LLC raised its holdings in shares of Intuitive Surgical by 7.0% during the third quarter. Avidian Wealth Enterprises LLC now owns 656 shares of the medical equipment provider’s stock worth $322,000 after acquiring an additional 43 shares in the last quarter. Concurrent Investment Advisors LLC grew its stake in Intuitive Surgical by 98.7% in the third quarter. Concurrent Investment Advisors LLC now owns 9,873 shares of the medical equipment provider’s stock valued at $4,850,000 after purchasing an additional 4,905 shares in the last quarter. Graypoint LLC increased its position in Intuitive Surgical by 7.5% in the 3rd quarter. Graypoint LLC now owns 2,496 shares of the medical equipment provider’s stock worth $1,226,000 after purchasing an additional 175 shares during the last quarter. Finally, BNC Wealth Management LLC raised its stake in shares of Intuitive Surgical by 5.4% during the 3rd quarter. BNC Wealth Management LLC now owns 10,545 shares of the medical equipment provider’s stock worth $5,180,000 after purchasing an additional 540 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on ISRG shares. Bernstein Bank boosted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Royal Bank of Canada boosted their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. CICC Research initiated coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price objective for the company. Finally, Barclays raised their target price on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $538.57 on Friday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm has a market capitalization of $191.83 billion, a P/E ratio of 84.02, a P/E/G ratio of 5.85 and a beta of 1.43. The company has a 50-day simple moving average of $571.70 and a 200-day simple moving average of $530.95.

Insider Activity

In related news, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares in the company, valued at approximately $208,181.75. This represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,090 shares of company stock worth $7,496,119. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.